Table 2.

Summary of Antimicrobic Administrations in P. aeruginosa Positive Patients

Variables	Pre-Pandemic (n = 131)	Post-Pandemic (n = 185)
β-Lactams n (%)	40 (30.5)	92 (50.0)**
CHBLs n (%)	1 (0.8)	3 (1.6)
Amino n (%)	11 (8.4)	29 (15.8)
Quinolones n (%)	34 (26.0)	53 (28.8)
Macrolides n (%)	1 (0.8)	6 (3.3)
Lincomycin n (%)	0 (0.0)	1 (0.5)
Short-term steroids n (%)	39 (30.0)	64 (35.2)

Notes: Pre-pandemic year: January 01, 2019-December 31, 2019; post-pandemic year: May 1, 2020-April 30, 2021. **P<0.01.

Abbreviation: CHBLs, carbapenemases.